bf/NASDAQ:ANIP_icon.jpeg

COM:ANIPHARMACEUTICALS

ANI Pharmaceuticals

  • Stock

USD

Last Close

61.05

07/03 21:00

Market Cap

1.31B

Beta: -

Volume Today

438.17K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
55.97M
-
76.32M
36.36%
128.62M
68.53%
176.84M
37.49%
201.58M
13.99%
206.55M
2.47%
208.47M
0.93%
216.14M
3.67%
316.38M
46.38%
486.82M
53.87%
cost of revenue
11.47M
-
12.69M
10.62%
48.78M
284.34%
79.03M
62.02%
73.02M
7.60%
63.15M
13.52%
87.16M
38.01%
100.61M
15.44%
138.78M
37.94%
241.30M
73.87%
gross profit
44.50M
-
63.63M
43.00%
79.84M
25.48%
97.81M
22.50%
128.55M
31.43%
143.39M
11.54%
121.32M
15.39%
115.53M
4.77%
177.60M
53.73%
245.51M
38.24%
selling and marketing expenses
general and administrative expenses
17.93M
-
21.16M
17.96%
27.83M
31.54%
31.58M
13.48%
44.06M
39.53%
selling general and administrative expenses
17.93M
-
21.16M
17.96%
27.83M
31.54%
31.58M
13.48%
44.06M
39.53%
55.84M
26.73%
64.99M
16.37%
84.29M
29.71%
124.04M
47.16%
161.70M
30.35%
research and development expenses
2.68M
-
2.87M
7.32%
2.91M
1.11%
9.07M
212.11%
15.39M
69.66%
19.81M
28.71%
16.00M
19.21%
11.37M
28.95%
22.32M
96.31%
34.29M
53.62%
other expenses
160K
-
41K
74.38%
-74K
280.49%
55K
174.32%
-550K
1,100%
51.32M
9,430.55%
55.90M
8.93%
48.03M
14.08%
56.97M
18.61%
-159K
100.28%
cost and expenses
35.96M
-
43.62M
21.29%
101.86M
133.50%
147.61M
44.92%
166.22M
12.61%
190.12M
14.38%
224.04M
17.84%
244.31M
9.04%
342.12M
40.04%
437.29M
27.82%
operating expenses
24.49M
-
30.93M
26.29%
53.08M
71.61%
68.58M
29.20%
93.19M
35.89%
126.97M
36.24%
136.89M
7.81%
143.69M
4.97%
203.33M
41.50%
195.98M
3.62%
interest expense
787K
-
11.01M
1,298.73%
11.33M
2.90%
12.04M
6.25%
14.76M
22.63%
12.97M
12.14%
9.45M
27.10%
11.92M
26.13%
28.05M
135.30%
27.52M
1.88%
ebitda
24.04M
-
39.64M
64.87%
49.03M
23.69%
57.22M
16.69%
68.55M
19.81%
60.81M
11.29%
28.57M
53.01%
14.74M
48.41%
31.91M
116.47%
109.32M
242.61%
operating income
20.01M
-
32.70M
63.45%
20.08M
38.60%
28.33M
41.09%
35.36M
24.82%
16.35M
53.76%
-16.06M
198.24%
-32.51M
102.39%
-25.06M
22.91%
49.53M
297.61%
depreciation and amortization
3.88M
-
6.90M
77.93%
22.34M
223.81%
27.93M
25.00%
33.74M
20.82%
44.46M
31.76%
44.64M
0.40%
47.25M
5.86%
56.97M
20.57%
59.79M
4.95%
total other income expenses net
160K
-
41K
74.38%
-6.76M
16,585.37%
-848K
87.45%
-550K
35.14%
-13.19M
2,298.91%
-9.90M
24.98%
-23.55M
137.89%
-37.60M
59.69%
-29.66M
21.13%
income before tax
19.38M
-
21.73M
12.15%
8.68M
60.07%
16.35M
88.40%
20.05M
22.64%
3.16M
84.26%
-25.96M
922.36%
-56.06M
115.92%
-62.66M
11.79%
19.87M
131.71%
income tax expense
-9.37M
-
6.36M
167.87%
4.74M
25.39%
17.43M
267.31%
4.56M
73.85%
-2.94M
164.45%
-3.41M
16.24%
-13.46M
294.11%
-14.77M
9.77%
1.09M
107.40%
net income
28.75M
-
15.38M
46.52%
3.93M
74.41%
-1.08M
127.35%
15.49M
1,539.96%
6.09M
60.67%
-22.55M
470.00%
-42.60M
88.94%
-47.90M
12.42%
18.78M
139.21%
weighted average shs out
10.94M
-
11.37M
3.92%
11.45M
0.66%
11.55M
0.89%
11.68M
1.13%
11.84M
1.40%
11.96M
1.04%
12.60M
5.28%
16.26M
29.09%
18.00M
10.71%
weighted average shs out dil
11.05M
-
11.56M
4.56%
11.57M
0.14%
11.55M
0.22%
11.77M
1.95%
12.04M
2.28%
11.96M
0.63%
12.60M
5.28%
16.26M
29.09%
18.19M
11.89%
eps
2.61
-
1.34
48.66%
0.34
74.63%
-0.09
127.41%
1.33
1,527.04%
0.51
61.65%
-1.88
468.63%
-3.38
79.79%
-2.95
12.72%
0.95
132.20%
epsdiluted
2.59
-
1.32
49.03%
0.34
74.24%
-0.09
127.41%
1.32
1,516.31%
0.50
62.12%
-1.88
476%
-3.38
79.79%
-2.95
12.72%
0.94
131.86%

All numbers in USD (except ratios and percentages)